[Therapeutic approach to Staphylococcus aureus bacteremia].
Staphylococcus aureus is an important human pathogen, responsible for 11-33% of the bacteremias acquired in the hospital setting and nearly 50% of those acquired in the community at large. The epidemiology of S. aureus bacteremia is discussed, with an special emphasis on the situation in Colombia and the resistance mechanisms against the major drug groups used for the treatment. The clinical keys and laboratory support for the appropriate clinical approaches are presented together with the therapeutic strategies for the treatment of patients with S. aureus bacteremia.
Tibavizco
Diego
D
Departamento de Medicina, Facultad de Medicina, Universidad Nacional de Colombia, Bogotá, D. C, Colombia.
Rodríguez
José Yesid
JY
Silva
Edwin
E
Cuervo
Sonia Isabel
SI
Cortés
Jorge Alberto
JA
D016470:Bacteremia / Q000175:diagnosis / Q000453:epidemiology / Q000382:microbiology / Q000628:therapy*; D003105:Colombia / Q000453:epidemiology; D003428:Cross Infection / Q000382:microbiology; D024901:Drug Resistance, Multiple, Bacterial; D006801:Humans; D013203:Staphylococcal Infections / Q000175:diagnosis / Q000453:epidemiology / Q000628:therapy*; D013211:Staphylococcus aureus / Q000472:pathogenicity*